Grane Rx is poised to take a leading role in promoting patient safety through precision medicine
Seattle, WA – August 8, 2017 – YouScript and Grane Rx announce today an agreement to deliver integrated YouScript precision prescribing support to post-acute care organizations.
Adverse drug events (ADEs) are a leading cause of avoidable hospitalization among the senior population. Each year, these events claim more than 100,000 lives and cause more than 700,000 emergency department visits. The vast majority of ADEs are caused by medications prescribed according to best practice guidelines.1
Traditional prescribing best practices, up until now, have not been able to account for individual patient physiology linked to drug metabolism within the body. As pay-for-performance models become more prominent, post-acute care providers will need tools that help them improve hospitalization rates and outcomes related to medication. Grane Rx’s Medication Insights™, powered by YouScript, provides this tool.
Utilizing a proprietary Risk Analysis dashboard, prescribers are alerted, in real-time, about patients are most vulnerable to significant medication-related problems. Potential issues are identified within the Risk Analysis software, and providers are able to instantly view and select alternative medications, both within the drug class, and for a specific therapeutic indication.
“The FDA has stated in drug development guidance that drug-gene interactions are as significant as drug-drug interactions,” said Kristine Ashcraft, Chief Executive Officer at YouScript. “I applaud Grane Rx for taking the lead to integrate this key information into medication management for our most vulnerable seniors.”
Recent studies2 in the home health environment showed that using YouScript can save approximately $4,382 per patient over a 60-day period, in addition to reducing hospitalizations and readmission rates by 52 percent and 42 percent respectively.
“As post-acute care shifts from a fee-for-service model to a pay-for-performance model, facilities will be penalized for excessive avoidable hospitalizations and poor outcomes,” said Bob Rowland, Chief Operating Officer at Grane Rx. “Polypharmacy is prominent in seniors, which increases their risk of adverse drug events that lead to hospitalization.
“This tool will offer newly available clinical insights to help prevent these events and avoidable hospitalizations related to ADE’s among post-acute care patients.”
YouScript will be available to all independent post-acute care organizations utilizing Grane Rx’s pharmacy services.
To learn how Medication Insights can benefit your organization, visit www.MedicationInsights.com to sign up for a free analysis.
Sources:
- Budnitz DS, Pollock DA, Weidenbach KN, Mendelsohn AB, Schroeder TJ, Annest JL. National Surveillance of Emergency Department Visits for Outpatient Adverse Drug Events. JAMA. 2006;296(15):1858-1866. doi:10.1001/jama.296.15.1858
- Elliott LS, Henderson JC, Neradilek MB, Moyer NA, Ashcraft KC, Thirumaran RK. (2017) Clinical impact of pharmacogenetic profiling with a clinical decision support tool in polypharmacy home health patients: A prospective pilot randomized controlled trial. PLOS ONE 12(2): e0170905. doi: 10.1371/journal.pone.0170905
